nivolumab,ipilimumab
bms
[' ipi ', '/ipi', 'nivo']
 i think two different studies would need to be done: 1) folfox-nivo +/- ipi in pdl1+
&amp; 2)folfox +/- nivo/ipi in pdl1-
(less enthusiastic as unlikely to be beneficial, but still reasonable to assess)
Medical Oncologist.                 "Targeted therapies for targeted populations”